Neochem Bio Solutions Ltd Forensic Report - SOIC x StockScans Report

as of Sep 2026

Neochem Bio Solutions Ltd's FY26 record is clean on its face: an unqualified audit opinion, all CARO clauses and internal-financial-controls checks came back clean, and no frauds were reported. The strain sits in the working-capital cycle: reported profit is not converting into operating cash, receivables have stretched to roughly 160 days, and the debt that remains is short-term and secured by promoter guarantees and pledged deposits.

Key findings

  1. Reported profit growth is not converting into operating cash Major - Cumulative operating cash flow was ₹4 crore against cumulative profit of ₹11 crore (excluding other income) over FY23-FY25, a 0.53x conversion ratio. In FY25 alone, CFO of ₹2.59 crore covered only 0.33x of PAT of ₹7.75 crore. Management attributed the negative FY23 cash flow to "increase in receivables while we have cleared a significant portion of the payables," expecting normalization "by the current fiscal year-end."
  2. Receivables are growing faster than revenue, with debtor days stretched to \~160 Major - Receivables stood at ₹25.28 crore in FY25 against revenue of ₹84.17 crore, with receivable days at 110 versus 103 in FY24. Management stated in the Q4 FY26 call that receivables of \~₹48 crores reflect "a weighted average of around 160 days," attributing the gap to a "temporary peak" from Q4 concentration. They acknowledged receivables are "going a little out of line" and aim to bring debtor days to "around 120 days, maybe by H1 FY27 or latest by the end of FY27."
  3. Reported debt reduction masks heavy reliance on short-term working-capital borrowings Major - Short-term borrowings were ₹21.35 crore of total borrowings of ₹35.62 crore (60%) in FY25, with cash at just ₹0.06 crore. Management stated in Q4 FY26 that long-term borrowings reduced to ₹0.7 crore from ₹14.3 crore and debt-to-equity improved from 1.8 to 0.2, while short-term borrowings stood at ₹17.1 crore. These facilities are secured by hypothecation of plant and machinery, mortgage of factory land, personal guarantees of directors, and pledged deposits.
  4. Clean audit opinions with two Emphasis of Matter items Minor - Patel Mehta & Associates issued an unqualified opinion for the year ended 31 March 2026, with no qualification or adverse remark. The auditor flagged an unrealised subsidy receivable of ₹4.85 crore and a ₹27.97 lakh receivable from an insolvent entity as Emphasis of Matter items, without modifying the opinion. All CARO clauses came back clean, including no default in loan repayments, no material fraud, and no cash losses.
  5. Accounting-policy changes and accruals are shifting reported profit between periods Minor - The company recognised a government subsidy receivable of ₹4.85 crore, including ₹2.48 crore in FY2025-26, which remained unrealised as at 31 March 2026. No gratuity provision was made until FY2023-24; provisioning began from FY2024-25, with a FY2025-26 provision of ₹1.13 crore. A ₹61.89 lakh exceptional item was charged for a change in labour law requiring revision of past gratuity provisions.
  6. A single disputed trade receivable is the only contingent litigation matter disclosed Minor - A receivable of ₹27.97 lakhs from Morarjee Textiles Ltd, against whom IBC insolvency proceedings were initiated, remains outstanding with no bad debt entry passed. The NCLT Mumbai Bench orally approved the resolution plan as of May 2026, with the written order still pending. No application was made nor proceedings were pending against the company under the IBC during FY2025-26.
  7. Promoter-led board with family ties and director consultancy payments Minor - The board comprised six directors as of 31 March 2026, with the Managing Director and Whole-time Director related as spouse. Consultancy charges of ₹14,10,000 were paid to a Non-Executive Director and ₹21,00,000 to another individual, with additional payments to entities connected with directors. No stock options were granted to any director, and promoter shareholding of 66.72% carries a 0.00% pledge.

What to watch

Bottom line: This is an audited record with clean opinions and no regulatory findings. The risk is concentrated in the cash conversion cycle: profits are booked but not collected, the subsidy is recognised but not received, and the debt that remains is short-term and personally guaranteed. Watch whether debtor days actually come down to \~120 days by end of FY27 and whether the subsidy and Morarjee receivables convert to cash.